Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus

US Patent 10478489 · Granted Nov 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-influenza neuraminidase monoclonal antibodies and uses thereof2025
Multivalent live-attenuated influenza vaccine for prevention and control of equi2025
Anti-influenza neuraminidase monoclonal antibodies and uses thereof2024
Multivalent live-attenuated influenza vaccine for prevention and control of equi2023
Broadly neutralizing anti-influenza human monoclonal antibody and uses thereof2021
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2021
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2021
Live-attenuated vaccine having mutations in viral polymerase for the treatment a2021
NS1 truncated virus for the development of canine influenza vaccines2021
NS1 truncated virus for the development of canine influenza vaccines2021
NS1 truncated virus for the development of canine influenza vaccines2021
Equine influenza virus live attenuated vaccines2020